Home›Companies›Healthcare›TDxS

Tidal Diagnostic Solutions Inc.

Makes infectious disease testing materials for laboratories, diagnostic manufacturers and researchers.

No LinkedIn page we could confirm. Why?
Updated Nov 11, 2026·Latest SEC filing Mar 3, 2026·Suggest an edit

About TDxS

TDxS is a private company based in Scarborough, Maine, incorporated in 2025 in Delaware. It has reported $247,000 raised in two offerings on Form D since October 2025. Its chief executive is David Kuhrt.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Mar 3, 2026Mar 3, 2026$20,000of $500K target1$20,000Options, Simple Agreement for Future EquityRule 506(b)Form D ↗
Oct 30, 2025Oct 17, 2025amended Jan 22, 2026$227,000of $300K target15$15,133Options, Simple Agreement for Future EquityRule 504Form D/A ↗1 earlier filing
Total, two offerings$247,000

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on TDxS's Form D filed Mar 3, 2026.

DK
David Kuhrt
Chief Executive Officer and director
SV
Suzanne Vogel
Chief Clinical & Regulatory Officer, director
TS
Tyler Schleicher
Chief Scientific Officer and director

Sources

  1. SECTidal Diagnostic Solutions Inc. Form D, filed Oct 17, 2025
  2. SECTidal Diagnostic Solutions Inc. filing history